ATE382362T1 - Verwendung und herstellung von saponinfreien spargelextrakten - Google Patents

Verwendung und herstellung von saponinfreien spargelextrakten

Info

Publication number
ATE382362T1
ATE382362T1 AT04022522T AT04022522T ATE382362T1 AT E382362 T1 ATE382362 T1 AT E382362T1 AT 04022522 T AT04022522 T AT 04022522T AT 04022522 T AT04022522 T AT 04022522T AT E382362 T1 ATE382362 T1 AT E382362T1
Authority
AT
Austria
Prior art keywords
saponin
production
extracts
free
saponine
Prior art date
Application number
AT04022522T
Other languages
English (en)
Inventor
Uwe Schnee
Original Assignee
Plantina Entwicklungs Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Plantina Entwicklungs Gmbh filed Critical Plantina Entwicklungs Gmbh
Application granted granted Critical
Publication of ATE382362T1 publication Critical patent/ATE382362T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
    • A61K36/8965—Asparagus, e.g. garden asparagus or asparagus fern
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/10—Antioedematous agents; Diuretics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Cardiology (AREA)
  • Microbiology (AREA)
  • Epidemiology (AREA)
  • Hematology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Diabetes (AREA)
  • Mycology (AREA)
  • Medical Informatics (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Obesity (AREA)
  • Child & Adolescent Psychology (AREA)
  • Nutrition Science (AREA)
  • Hospice & Palliative Care (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Steroid Compounds (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
AT04022522T 2004-09-22 2004-09-22 Verwendung und herstellung von saponinfreien spargelextrakten ATE382362T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP04022522A EP1640016B1 (de) 2004-09-22 2004-09-22 Verwendung und Herstellung von saponinfreien Spargelextrakten

Publications (1)

Publication Number Publication Date
ATE382362T1 true ATE382362T1 (de) 2008-01-15

Family

ID=34926656

Family Applications (1)

Application Number Title Priority Date Filing Date
AT04022522T ATE382362T1 (de) 2004-09-22 2004-09-22 Verwendung und herstellung von saponinfreien spargelextrakten

Country Status (10)

Country Link
US (1) US20070292543A1 (de)
EP (1) EP1640016B1 (de)
JP (1) JP2008513530A (de)
KR (1) KR20070065400A (de)
CN (1) CN101031337A (de)
AT (1) ATE382362T1 (de)
AU (1) AU2005287542A1 (de)
CA (1) CA2578735A1 (de)
DE (1) DE602004011059T2 (de)
WO (1) WO2006032510A1 (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2006111583A (ja) * 2004-10-15 2006-04-27 Unitika Ltd γ−アミノ酪酸含有組成物及びその製造方法
WO2009007774A1 (en) * 2006-07-07 2009-01-15 Avestha Gengraine Technologies Pvt. Ltd. Asparagus racemosa extracts for treating osteoporosis and the extraction process thereof
CN101559157B (zh) * 2009-05-18 2012-08-22 华东师范大学 一种利用芦笋渣分级提取芦笋皂苷和芦笋多糖的方法
CN102640840A (zh) * 2012-05-23 2012-08-22 江西省农业科学院畜牧兽医研究所 一种芦笋秸秆提取物饲料添加剂及其制备方法
CN102839137B (zh) * 2012-07-27 2013-10-16 长安大学 一种用于降解石油的固体微生物菌剂及其制备方法
JP6735518B2 (ja) * 2015-01-06 2020-08-05 国立研究開発法人理化学研究所 新規アンジオテンシン変換酵素阻害剤
CN106421494A (zh) * 2016-12-01 2017-02-22 秦皇岛长胜营养健康科技有限公司 芦笋提取物在制备提升和改善记忆力保健品或保健药物中的应用
US10543158B2 (en) * 2017-04-17 2020-01-28 W Skincare, LLC Autophagy activating complex, compositions and methods
CN110327431A (zh) * 2019-07-30 2019-10-15 上海市农业科学院 芦笋提取物在制备治疗炎症的药物中的应用及药物
CN114668143A (zh) * 2022-04-24 2022-06-28 麻城市正旺芦笋农业科技股份有限公司 一种芦笋营养成分提取分离方法
CN114869816B (zh) * 2022-05-09 2024-11-08 惠州腾大健康科技有限公司 一种马齿苋提取物组合物

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS63273462A (ja) * 1987-05-01 1988-11-10 Marutomo Kk アスパラガスを原料とした粉末茶並に抽出茶液
US6670459B2 (en) * 2002-03-20 2003-12-30 Zandu Pharmaceutical Works Ltd. Process for the isolation of novel oligospirostanoside
US6994874B2 (en) * 2003-04-16 2006-02-07 Access Business Group International, Llc Skin whitening compositions containing asparagus extract

Also Published As

Publication number Publication date
KR20070065400A (ko) 2007-06-22
JP2008513530A (ja) 2008-05-01
CN101031337A (zh) 2007-09-05
AU2005287542A1 (en) 2006-03-30
US20070292543A1 (en) 2007-12-20
CA2578735A1 (en) 2006-03-30
DE602004011059T2 (de) 2009-01-02
DE602004011059D1 (de) 2008-02-14
EP1640016A1 (de) 2006-03-29
EP1640016B1 (de) 2008-01-02
WO2006032510A1 (en) 2006-03-30

Similar Documents

Publication Publication Date Title
DK1807083T3 (da) Anvendelse af pirlindol til behandling af lidelser, der er kendetegnet ved proliferation af T-lymphocyter og/eller hyperproliferation af keratinocyter, især atopisk dermatitis og psoriasis
EA200801632A1 (ru) Экстракт, обогащенный проантоцианидинами, и способ его получения
WO2004041184A3 (en) Nutraceutical mangosteen composition
ATE382362T1 (de) Verwendung und herstellung von saponinfreien spargelextrakten
NO20073900L (no) Anvendelse av LGG for fremstilling av et medikament for forebygging eller behandling av respiratoriske sykdommer
DE502005008790D1 (de) Substituierte phenylaminopyrimidine
MX2009011869A (es) Aislados antimicrobianos y anti-inflamatorios de extracto de regaliz.
ATE543519T1 (de) Verwendung eines hämoglobins zur herstellung von verbänden und daraus resultierende verbände
WO2012033634A3 (en) Topical skin care formulations comprising plant extracts
ATE519373T1 (de) Teezusammensetzung und herstellungsverfahren dafür
DK1687015T3 (da) Sammensætninger til behandling af sygdomme i mundhulen og øvre åndedrætsorgan
EP4321504A4 (de) Pegyliertes lipid und damit modifiziertes liposom sowie pharmazeutische zusammensetzung mit liposom sowie herstellung und verwendung davon
ATE497932T1 (de) Auf siliciumdioxid basierende sole und ihre herstellung und verwendung
WO2007030666A3 (en) Medicated skin care preparation for promoting wound healing
EP1510217A4 (de) Antirheumatikum und verfahren zu seiner herstellung
BRPI0601933A (pt) processo para a fabricação de uma composição enriquecida com teobromina, e uma composição enriquecida com polifenol a partir de cascas de cacau, e, composição enriquecida com polifenol
BRPI0412803A (pt) alfa-fetoproteìna humana não-glicosilada, métodos de produção e usos dos mesmos
PT1942874E (pt) Composição herbal para gestão do peso
EP1702508A4 (de) Verfahren zur herstellung einer sterilen pflanze, durch das verfahren erhaltene pflanze und verwendung davon
DE60331999D1 (de) Hautaufhellende zusammensetzung
DE602005020859D1 (de) Entschleimte flachskeimlinge und ihr nebenprodukt sowie ihre herstellung und verwendung
WO2007024510A3 (en) Medicinal herbal composition for treating infection
WO2010109318A8 (en) Process for the preparation of herbal extract of cassia tora leaves for treating anxiety disorders
ITRM20040393A1 (it) Composizione naturale con proprieta' cicatrizzante, repellente e biocida per il trattamento e la risoluzione delle lesioni esterne.
ATE410443T1 (de) Heterocyclyl-substituierte nonadepsipeptide

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1640016

Country of ref document: EP